Guaitoli G - Search Results

1

Treating cancer with immunotherapy in HIV-positive patients: A challenging reality.

Guaitoli G, Baldessari C, Maur M, Mussini C, Meschiari M, Barbieri F, Cascinu S, Bertolini F. Guaitoli G, et al. Crit Rev Oncol Hematol. 2020 Jan;145:102836. doi: 10.1016/j.critrevonc.2019.102836. Epub 2019 Nov 26. Crit Rev Oncol Hematol. 2020. PMID: 31918216 Review.

2

Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.

Omarini C, Guaitoli G, Noventa S, Andreotti A, Gambini A, Palma E, Papi S, Tazzioli G, Balduzzi S, Dominici M, Cascinu S, Piacentini F. Omarini C, et al. Among authors: guaitoli g. Eur J Surg Oncol. 2017 Apr;43(4):613-618. doi: 10.1016/j.ejso.2016.09.020. Epub 2016 Oct 20. Eur J Surg Oncol. 2017. PMID: 27793416

3

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.

Cazzaniga ME, Airoldi M, Arcangeli V, Artale S, Atzori F, Ballerio A, Bianchi GV, Blasi L, Campidoglio S, Ciccarese M, Cursano MC, Piezzo M, Fabi A, Ferrari L, Ferzi A, Ficorella C, Frassoldati A, Fumagalli A, Garrone O, Gebbia V, Generali D, La Verde N, Maur M, Michelotti A, Moretti G, Musolino A, Palumbo R, Pistelli M, Porpiglia M, Sartori D, Scavelli C, Schirone A, Turletti A, Valerio MR, Vici P, Zambelli A, Clivio L, Torri V; on behalf of; EVA Study Group. Cazzaniga ME, et al. Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13. Breast. 2017. PMID: 28711793

4

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.

Omarini C, Guaitoli G, Pipitone S, Moscetti L, Cortesi L, Cascinu S, Piacentini F. Omarini C, et al. Among authors: guaitoli g. Cancer Manag Res. 2018 Jan 15;10:91-103. doi: 10.2147/CMAR.S146658. eCollection 2018. Cancer Manag Res. 2018. PMID: 29391830 Free PMC article. Review.

5

Late Gastrointestinal Toxicity During Nivolumab Therapy in Non-Small Cell Lung Cancer: A Rare Case of Inflammatory Bowel Disease.

Guaitoli G, Baldessari C, Tomasello C, Barbieri F, Cascinu S, Bertolini F, Cesinaro AM. Guaitoli G, et al. J Thorac Oncol. 2018 Aug;13(8):e152-e153. doi: 10.1016/j.jtho.2018.03.022. J Thorac Oncol. 2018. PMID: 30049380 Free article. No abstract available.

6

Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.

Omarini C, Bettelli S, Caprera C, Manfredini S, Caggia F, Guaitoli G, Moscetti L, Toss A, Cortesi L, Kaleci S, Maiorana A, Cascinu S, Conte PF, Piacentini F. Omarini C, et al. Among authors: guaitoli g. Cancer Biol Ther. 2018;19(10):879-886. doi: 10.1080/15384047.2018.1480287. Epub 2018 Aug 1. Cancer Biol Ther. 2018. PMID: 30067438 Free PMC article.

7

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus.

Omarini C, Filieri ME, Bettelli S, Manfredini S, Kaleci S, Caprera C, Nasso C, Barbolini M, Guaitoli G, Moscetti L, Maiorana A, Conte PF, Cascinu S, Piacentini F. Omarini C, et al. Among authors: guaitoli g. Biomed Res Int. 2018 Jul 24;2018:3756981. doi: 10.1155/2018/3756981. eCollection 2018. Biomed Res Int. 2018. PMID: 30140695 Free PMC article.

8

Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy.

Guaitoli G, Piacentini F, Omarini C, Andreotti A, Palma E, Papi S, De Pietri C, Conti A, Cascinu S, Tazzioli G. Guaitoli G, et al. Breast Cancer. 2019 Jul;26(4):520-523. doi: 10.1007/s12282-018-00940-5. Epub 2018 Dec 18. Breast Cancer. 2019. PMID: 30564995

9

Are we ready to describe response or progression to immunotherapy in lung cancer?

Guaitoli G, Baldessari C, Bertolini F, Tomasello C, Cascinu S, Barbieri F. Guaitoli G, et al. Crit Rev Oncol Hematol. 2019 Jun;138:112-119. doi: 10.1016/j.critrevonc.2019.04.002. Epub 2019 Apr 4. Crit Rev Oncol Hematol. 2019. PMID: 31092366 Review.

10

Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma.

Losi L, Bertolini F, Guaitoli G, Fabbiani L, Banchelli F, Ambrosini-Spaltro A, Botticelli L, Scurani L, Baldessari C, Barbieri F, Cascinu S, Maiorana A. Losi L, et al. Among authors: guaitoli g. Int J Oncol. 2019 Nov;55(5):1157-1164. doi: 10.3892/ijo.2019.4883. Epub 2019 Sep 20. Int J Oncol. 2019. PMID: 31545419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters